News Focus
News Focus
icon url

dcaf7

12/05/24 9:27 AM

#224 RE: KRISGO #222

Nothing really changed. Rolvedon doesn't look different from Neulasta and multiple biosimilars. Sales have remained flat over the last three quarters.